Evidence map›Paper›PMID 35090533›Full record

ArticleTrials2022

Activities supporting the growth of Clinical Trial Networks in Australia.

Fiona Nemeh, Rachelle Buchbinder, Carmel M Hawley, Mark R Nelson, Jacqui G Waterkeyn, Christopher M Reid

Abstract readLetter
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fiona NemehAustralian Clinical Trials Alliance, Melbourne, Victoria, Australia.
Rachelle BuchbinderDepartment of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia.
Carmel M HawleyDepartment of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
Mark R NelsonAustralian Clinical Trials Alliance, Melbourne, Victoria, Australia.
Jacqui G WaterkeynOrygen, Parkville, Victoria, Australia.
Christopher M ReidAustralian Clinical Trials Alliance, Melbourne, Victoria, Australia. christopher.reid@curtin.edu.au.ORCID http://orcid.org/0000-0001-9173-3944

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical Trial Networks in which trialists work collaboratively enable multi-site, large-scale, high-quality clinical trials to be efficiently run. Although the benefits of Clinical Trial Networks are largely known, establishing a Clinical Trial Network can be complex. There are many factors for clinicians and researchers to consider, and there is currently a paucity of information on how to form a Clinical Trial Network. This article provides a suggested roadmap on how to establish a Clinical Trial Network. The Australian Clinical Trials Alliance (ACTA) is the peak body for Clinical Trial Networks, Coordinating Centres and Registries in Australia, and has produced several resources to support the effective and efficient running of clinical trials. This guide has come about through discussions with members of the ACTA Clinical Trial Network Sector Expansion Reference Group consisting of clinical trialists, clinicians, researchers, and consumers.

Indexed as

Research PersonnelResearch ReportAustraliaHumansRegistriesClinical trialClinical Trial NetworkCollaborationEstablishRoadmap

Identifiers

PMID35090533
PMCPMC8795956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.